HK Stock Market Move | BIODLINK-B (01875) resumes trading with a more than 58% opening increase, with WUXI XDC offering a cash tender offer at a premium of approximately 99%.

After resumption of trading, BIODLINK-B (01875) opened significantly higher, up 58.8% to HKD 3.97 as of the time of writing, with a trading volume of HKD 1.1211 million. On the news front, Dongyao Pharmaceutical and WUXI XDC (02268) jointly announced that WUXI XDC has proposed a voluntary offer to acquire all shares of Dongyao Pharmaceutical at a cash price of HKD 4 per share, representing a premium of approximately 99.00% over the closing price of HKD 2.01 per share before the trading halt. The maximum consideration of the offer is approximately HKD 2.79 billion. The offeror intends to maintain the listing of the shares on the Stock Exchange upon completion.